Publications by authors named "Roy First"

Claim this Profile
F
Forty-Year Survival of Simultaneous Kidney and Duct-Injected Segmental Pancreas Transplants in a Recipient Maintained on Low-Dose Azathioprine and Prednisone.
Amit Govil, Rino Munda, M Roy First

Transplant Proc· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TAK-101 Nanoparticles Induce Gluten-Specific Tolerance in Celiac Disease: A Randomized, Double-Blind, Placebo-Controlled Study.
Ciarán P Kelly, Joseph A Murray, Daniel A Leffler, Daniel R Getts, Adam C Bledsoe, M Roy First

Gastroenterology· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early Corticosteroid Cessation vs Long-term Corticosteroid Therapy in Kidney Transplant Recipients: Long-term Outcomes of a Randomized Clinical Trial.
E Steve Woodle, John S Gill, Stephanie Clark, Darren Stewart, Rita Alloway, Roy First

JAMA Surg· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Avoiding surveillance biopsy: Use of a noninvasive biomarker assay in a real-life scenario.
Audrey Ang, Courtney Schieve, Stanley Rose, Clifton Kew, M Roy First

Clin Transplant· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Kidney Graft Surveillance Biopsy Utilization and Trends: Results From a Survey of High-Volume Transplant Centers.
Darren M Lee, Michael M Abecassis, John J Friedewald, Stanley Rose, M Roy First

Transplant Proc· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serial Peripheral Blood Gene Expression Profiling to Assess Immune Quiescence in Kidney Transplant Recipients with Stable Renal Function.
V Ram Peddi, Parul S Patel, Courtney Schieve, Stan Rose, M Roy First

Ann Transplant· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The importance of drug safety and tolerability in the development of new immunosuppressive therapy for transplant recipients: The Transplant Therapeutics Consortium's position statement.
Mark D Stegall, Kenneth Troy Somerville, Matthew J Everly, Roslyn B Mannon, A Osama Gaber, M Roy First

Am J Transplant· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics of prolonged-release tacrolimus and implications for use in solid organ transplant recipients.
Maria G Tanzi, Nasrullah Undre, James Keirns, William E Fitzsimmons, Malcolm Brown, M Roy First

Clin Transplant· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interleukin-2 receptor antagonist therapy leads to increased tacrolimus levels after kidney transplantation.
Sonia Lin, Alice K Henning, Fatemeh Akhlaghi, Robin Reisfield, Andrea Vergara-Silva, M Roy First

Ther Drug Monit· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of tacrolimus absorption from the human intestinal tract: open-label, randomized, 4-way crossover study.
Daisuke Tsunashima, Akio Kawamura, Manabu Murakami, Taiji Sawamoto, Nas Undre, Roy First

Clin Ther· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term follow-up of a phase III clinical trial comparing tacrolimus extended-release/MMF, tacrolimus/MMF, and cyclosporine/MMF in de novo kidney transplant recipients.
Hélio Tedesco Silva, Harold C Yang, Herwig-Ulf Meier-Kriesche, Richard Croy, John Holman, M Roy First

Transplantation· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New-onset diabetes after transplantation (NODAT): an evaluation of definitions in clinical trials.
M Roy First, Shobha Dhadda, Richard Croy, John Holman, William E Fitzsimmons

Transplantation· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute rejection characteristics from a prospective, randomized, double-blind, placebo-controlled multicenter trial of early corticosteroid withdrawal.
A Osama Gaber, Linda W Moore, Rita R Alloway, E Steve Woodle, John Pirsch, M Roy First

Transplantation· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alemtuzumab induction in renal transplantation.
Michael J Hanaway, E Steve Woodle, Shamkant Mulgaonkar, V Ram Peddi, Dixon B Kaufman, M Roy First

N Engl J Med· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of efficacy and safety of FK778 in comparison with standard care in renal transplant recipients with untreated BK nephropathy.
Antonio Guasch, Prabir Roy-Chaudhury, E Steve Woodle, William Fitzsimmons, John Holman, M Roy First

Transplantation· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
De novo cancers arising in organ transplant recipients are associated with adverse outcomes compared with the general population.
Yun Miao, Jason J Everly, Thomas G Gross, Amit D Tevar, M Roy First

Transplantation· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A prospective trial of a steroid-free/calcineurin inhibitor minimization regimen in human leukocyte antigen (HLA)-identical live donor renal transplantation.
Jennifer K Walker, Rita R Alloway, Prabir Roy-Chaudhury, Gautham Mogilishetty, Michael A Cardi, M Roy First

Transplantation· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A prospective, randomized, double-blind, placebo-controlled multicenter trial comparing early (7 day) corticosteroid cessation versus long-term, low-dose corticosteroid therapy.
E Steve Woodle, M Roy First, John Pirsch, Fuad Shihab, A Osama Gaber

Ann Surg· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corticosteroid elimination: the Cincinnati experience.
E Steve Woodle, Rita Alloway, Adele Rike, Prabir Roy-Chaudhury, Amit Tevar, M Roy First

Clin Transpl· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimizing tacrolimus therapy in the maintenance of renal allografts: 12-month results.
Paul Bolin, Fuad S Shihab, Laura Mulloy, Alice K Henning, Jeff Gao, M Roy First

Transplantation· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Conversion from cyclosporine to tacrolimus in patients at risk for chronic renal allograft failure: 60-month results of the CRAF Study.
Fuad S Shihab, Thomas H Waid, David J Conti, Harold Yang, Michael J Holman, M Roy First

Transplantation· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First clinical experience with the new once-daily formulation of tacrolimus.
M Roy First

Ther Drug Monit· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Once-daily tacrolimus extended release formulation: experience at 2 years postconversion from a Prograf-based regimen in stable liver transplant recipients.
Sander Florman, Rita Alloway, Munci Kalayoglu, Jeffrey Punch, Thomas Bak, M Roy First

Transplantation· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Two years postconversion from a prograf-based regimen to a once-daily tacrolimus extended-release formulation in stable kidney transplant recipients.
Rita Alloway, Steven Steinberg, Kassem Khalil, Sita Gourishankar, Joshua Miller, M Roy First

Transplantation· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
One-year results with extended-release tacrolimus/MMF, tacrolimus/MMF and cyclosporine/MMF in de novo kidney transplant recipients.
H T Silva, H C Yang, M Abouljoud, P C Kuo, K Wisemandle, M Roy First

Am J Transplant· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis